Shares of Teladoc Health Inc. (NYSE: TDOC), a leading provider of virtual healthcare services, surged 6.6% on Wednesday, outperforming the broader market amid growing optimism about the company's growth prospects.
The rally was fueled by Teladoc's recent collaboration with Amazon.com to expand the availability of its chronic condition management programs. Under the agreement, qualifying Amazon customers can access Teladoc's services for pre-diabetes, diabetes, weight management, and hypertension through Amazon's Health Benefits Program.
Additionally, Teladoc announced plans to acquire Catapult Health, a digital preventive care services provider, for $65 million in cash, with an additional $5 million in performance-based compensation. This acquisition is expected to strengthen Teladoc's comprehensive care solutions by integrating Catapult Health's patient-focused approach to personalized supportive care and at-home testing.
Teladoc's strong performance year-to-date, with a gain of 57.65% as of February 17, 2025, has also contributed to investor enthusiasm. The company ranks among the best-performing healthcare stocks this year, reflecting its market-leading position and the growing demand for virtual healthcare services.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。